Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01587820 · ClinicalTrials.gov registry record · Early Phase 1
Intra-arterial Versus Intravenous Cisplatin, Combined With Radiation, for Oral Cavity and Oropharynx Cancer
A Early Phase 1 study, sponsored by Southern Illinois University.
- Terminated
- Registry status
- Early Phase 1
- Development phase
- 1
- Enrollment target
NCT01587820 is a Early Phase 1 study that was terminated before completion, run by Southern Illinois University. The registered enrollment target is 1 participants.
The verdict
NCT01587820, a Early Phase 1 study, was terminated before completion, sponsored by Southern Illinois University.
- TERMINATED
- Registry status
- Early Phase 1
- Development phase
- 1 participants
- Enrollment target
Study Summary
This is a randomized, open-label investigator initiated pilot/ feasibility study comparing the effectiveness of intra-arterial administration of cisplatin therapy to intravenous administration of cisplatin when each is combined with the radiation therapy found in standard care. Participants will be randomized to either intra-arterial or intravenous cisplatin chemotherapy. This study is designed to determine whether a large scale study is practical in the investigators clinical setting. Approximately 10 subjects will be enrolled over a 2 year period.
Interventions
- DRUG Intra-arterial cisplatin
- DRUG Intravenous cisplatin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2012-06 |
| Est. Completion | 2014-08 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01587820
The ClinicalTrials.gov registry entry for NCT01587820 describes a study currently listed as terminated, categorized as Early Phase 1. The registered enrollment target is 1 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Southern Illinois University, which has 21 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Intra-arterial cisplatin is the first listed.
NCT01587820 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01587820 about?
NCT01587820 is a clinical study titled "Intra-arterial Versus Intravenous Cisplatin, Combined With Radiation, for Oral Cavity and Oropharynx Cancer". This is a randomized, open-label investigator initiated pilot/ feasibility study comparing the effectiveness of intra-arterial administration of cisplatin therapy to intravenous administration of cisplatin when each is combined with the radiation therapy found in standard care. Participants will be ...
What is the current status of trial NCT01587820?
This trial is currently terminated. It is a Early Phase 1 study. The enrollment target is 1 participants. The study started on 2012-06. Estimated completion is 2014-08.
What interventions are being tested in trial NCT01587820?
The interventions under investigation include: Intra-arterial cisplatin (DRUG), Intravenous cisplatin (DRUG).
Who is sponsoring clinical trial NCT01587820?
This trial is sponsored by Southern Illinois University, which has 21 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.